Dr. Sai Nandi leads Immune Boost Capital, guiding the firm's strategic vision and overseeing its venture investment portfolio. He is a seasoned life sciences investor and operator with more than two decades of leadership at the intersection of venture capital, institutional investing, and company building.
Investment Leadership
His career reflects a consistent focus on identifying breakthrough science early, scaling high-growth biopharmaceutical companies, and driving strategic value across the healthcare ecosystem. Sai previously served as a Portfolio Manager at AIG Investments and held senior investment roles across multiple global asset management firms, where he managed public and private healthcare portfolios exceeding $1 billion.
His strategic leadership has shaped the growth trajectories of numerous biopharmaceutical companies, informed by deep scientific insight and disciplined investment judgment.
Board & Executive Experience
In addition to his investment expertise, he has held C-suite roles, including Chief Business Officer at Oryzon, and served on the boards of more than 10 biotech and healthcare technology companies, guiding teams across financing, M&A, business development, and clinical operations.
His investment and board experience spans industry-leading innovators including Roivant Sciences, BridgeBio Pharma, ElevateBio, Cullinan Therapeutics, Fractyl Health, AlloVir, SQZ Biotech, and Atomwise.
Scientific Foundation
Sai holds a D.Phil. (Ph.D.) from the University of Oxford in Biochemistry, where he was a SKP Clarendon Scholar, and served as a Visiting Scientist at Cold Spring Harbor Laboratory, where he was awarded the NCI NYSTAR Fellowship. He has authored peer-reviewed publications in Science, Nature, and Molecular Cell.